Google and LegitScript Raise Bar for Health Ads in India, NZ

PORTLAND, Ore. – April 08, 2026 – In a significant move to regulate the booming digital healthcare space, Google has expanded its partnership with compliance firm LegitScript, introducing a mandatory certification requirement for online pharmacies in India and telemedicine providers in New Zealand wishing to advertise on its platform.

The policy, which took effect this month, designates LegitScript as the gatekeeper for these high-growth markets. Eligible businesses must now first secure a LegitScript Healthcare Certification before they can apply to run Google Ads, a process intended to filter out non-compliant operators and enhance patient safety online.

This expansion comes as both nations experience explosive growth in digital health adoption. India's online pharmacy market is projected to exceed $14 billion by 2034, while New Zealand has seen a 30% increase in telehealth users over the past five years, with approximately 1.2 million Kiwis now accessing remote care.

"Our continued collaboration with Google helps ensure that certified providers in India and New Zealand can reach patients through trusted advertising platforms while maintaining transparency and good practices,” said Angela Salter, VP of Enterprise Certification Sales at LegitScript, in a statement.

The New Digital Gatekeepers

Under the updated Google Ads policy, healthcare providers in the specified sectors must navigate a two-step verification process. First, they must apply for and receive LegitScript Healthcare Certification. This involves a rigorous review where LegitScript assesses a provider's licensure, prescribing practices, patient privacy protections, and advertising transparency against a set of stringent standards.

Once certified, businesses receive a unique certification seal and are listed in LegitScript’s database. They must then submit a separate application directly to Google, providing their certification details for verification. Only after Google approves this application can their ads for restricted healthcare services run. Google has stated that it will issue a warning at least seven days prior to any account suspension for non-compliance, avoiding immediate shutdowns.

The move solidifies LegitScript's role as a key third-party arbiter for some of the internet's most sensitive advertising categories. The firm already holds a similar position for addiction treatment centers in the U.S. and its certification is recognized by payment processors like Visa and Mastercard.

“In the past year alone, LegitScript has seen a 103% increase in certified healthcare organizations,” noted Jaylene Kunze, the company's Chief Operating & Financial Officer. This reflects a broader trend of online platforms outsourcing complex regulatory vetting to specialized firms.

Navigating a Complex Regulatory Maze

The partnership arrives as national regulators in both India and New Zealand are racing to keep pace with the digital transformation of healthcare.

In New Zealand, the policy aligns with government efforts to formalize telehealth. The country’s Medicines Amendment Act 2025 has already streamlined drug approval pathways and expanded prescribing rights for nurse practitioners and pharmacists, creating a more favorable environment for digital health services. Simultaneously, New Zealand's Advertising Standards Authority (ASA) has tightened its Therapeutic and Health Advertising Code, imposing stricter rules on evidence for claims and the use of testimonials, particularly for vulnerable audiences.

The situation in India is more nuanced. While Google's policy now allows certified online pharmacies to promote their prescription drug services, it maintains a restriction on promoting specific prescription drugs in ad copy or on landing pages. This distinction is critical, aiming to allow legitimate pharmacies to build brand awareness without engaging in the direct-to-consumer advertising of medications, a practice that remains heavily regulated.

For both regions, data privacy remains a paramount concern. Google’s own ad policies prohibit advertisers from using personalized advertising techniques like retargeting or targeting users based on health interests, creating a baseline of privacy protection that certified providers must also respect in addition to local data protection laws.

The Price of Trust: A Barrier or a Boon?

While the new certification requirement is positioned as a mark of quality and trust, it introduces a significant financial and administrative hurdle for local providers, particularly small and medium-sized enterprises.

The cost of obtaining LegitScript certification is not trivial. Providers face initial application fees ranging from approximately $975 to $1,500. On top of that, annual renewal fees can range from $1,295 for a standard pharmacy to over $2,500 for a more complex telemedicine operation. These fees can increase if compliance issues are found during the review process.

The application itself is an exhaustive process that can take weeks or even months to complete. Applicants must submit extensive documentation covering business registration, professional licenses, and detailed operational policies. This creates a potential barrier to entry, where only more established or well-funded providers may have the resources to complete the process and unlock access to Google's vast advertising network.

For those who successfully navigate the process, however, the certification offers a clear competitive advantage. The LegitScript seal serves as a powerful signal of credibility to consumers, differentiating certified providers from unregulated competitors. In markets flooded with new entrants, this verified status can be a crucial factor in building patient trust and capturing market share, effectively turning a regulatory requirement into a valuable business asset. The new framework essentially makes compliance a prerequisite for growth in the digital healthcare sector.